CN111671865A - Compact antibacterial anti-vaginitis medicine containing capsule formula for female private nursing - Google Patents
Compact antibacterial anti-vaginitis medicine containing capsule formula for female private nursing Download PDFInfo
- Publication number
- CN111671865A CN111671865A CN202010665764.8A CN202010665764A CN111671865A CN 111671865 A CN111671865 A CN 111671865A CN 202010665764 A CN202010665764 A CN 202010665764A CN 111671865 A CN111671865 A CN 111671865A
- Authority
- CN
- China
- Prior art keywords
- vaginitis
- formula
- nano
- antibacterial anti
- percent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 98
- 206010046914 Vaginal infection Diseases 0.000 title claims abstract description 33
- 201000008100 Vaginitis Diseases 0.000 title claims abstract description 33
- 230000000844 anti-bacterial effect Effects 0.000 title claims abstract description 32
- 239000007963 capsule composition Substances 0.000 title claims abstract description 27
- 230000000474 nursing effect Effects 0.000 title description 2
- 229940079593 drug Drugs 0.000 claims abstract description 36
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 35
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 18
- 240000004510 Agastache rugosa Species 0.000 claims abstract description 15
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 14
- 240000001717 Vaccinium macrocarpon Species 0.000 claims abstract description 14
- 235000012545 Vaccinium macrocarpon Nutrition 0.000 claims abstract description 14
- 235000002118 Vaccinium oxycoccus Nutrition 0.000 claims abstract description 14
- 235000004634 cranberry Nutrition 0.000 claims abstract description 14
- 208000007074 Trichomonas Vaginitis Diseases 0.000 claims abstract description 13
- 208000025206 Trichomonas vaginitis urogenital infection Diseases 0.000 claims abstract description 13
- 235000001667 Vitex agnus castus Nutrition 0.000 claims abstract description 13
- 244000063464 Vitex agnus-castus Species 0.000 claims abstract description 13
- 235000009347 chasteberry Nutrition 0.000 claims abstract description 13
- 239000006041 probiotic Substances 0.000 claims abstract description 12
- 235000018291 probiotics Nutrition 0.000 claims abstract description 12
- 241000212948 Cnidium Species 0.000 claims abstract description 11
- 235000004347 Perilla Nutrition 0.000 claims abstract description 10
- 244000124853 Perilla frutescens Species 0.000 claims abstract description 10
- 229930003427 Vitamin E Natural products 0.000 claims abstract description 7
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims abstract description 7
- 235000019165 vitamin E Nutrition 0.000 claims abstract description 7
- 229940046009 vitamin E Drugs 0.000 claims abstract description 7
- 239000011709 vitamin E Substances 0.000 claims abstract description 7
- 241000193830 Bacillus <bacterium> Species 0.000 claims abstract description 6
- 235000009754 Vitis X bourquina Nutrition 0.000 claims abstract description 5
- 235000012333 Vitis X labruscana Nutrition 0.000 claims abstract description 5
- 240000006365 Vitis vinifera Species 0.000 claims abstract description 5
- 235000014787 Vitis vinifera Nutrition 0.000 claims abstract description 5
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 claims abstract description 4
- 235000003097 Artemisia absinthium Nutrition 0.000 claims abstract description 4
- 240000001851 Artemisia dracunculus Species 0.000 claims abstract description 4
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 claims abstract description 4
- 235000003261 Artemisia vulgaris Nutrition 0.000 claims abstract description 4
- 241000212322 Levisticum officinale Species 0.000 claims abstract description 4
- 241000234435 Lilium Species 0.000 claims abstract description 4
- 239000001138 artemisia absinthium Substances 0.000 claims abstract description 4
- 239000001645 levisticum officinale Substances 0.000 claims abstract description 4
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims abstract description 4
- 235000006679 Mentha X verticillata Nutrition 0.000 claims description 21
- 235000002899 Mentha suaveolens Nutrition 0.000 claims description 21
- 235000001636 Mentha x rotundifolia Nutrition 0.000 claims description 21
- 239000000843 powder Substances 0.000 claims description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 13
- 235000011187 glycerol Nutrition 0.000 claims description 12
- 239000009186 Vitex agnus castus extract Substances 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 10
- 241000037740 Coptis chinensis Species 0.000 claims description 7
- 241000218691 Cupressaceae Species 0.000 claims description 7
- 238000000227 grinding Methods 0.000 claims description 7
- 240000009022 Smilax rotundifolia Species 0.000 claims description 6
- 235000003205 Smilax rotundifolia Nutrition 0.000 claims description 6
- 241001116389 Aloe Species 0.000 claims description 5
- 241000253115 Carpesium Species 0.000 claims description 5
- 241000099774 Cuscuta salina Species 0.000 claims description 5
- 241000195955 Equisetum hyemale Species 0.000 claims description 5
- 241001062811 Stewartia malacodendron Species 0.000 claims description 5
- 235000011399 aloe vera Nutrition 0.000 claims description 5
- 244000061520 Angelica archangelica Species 0.000 claims description 4
- 235000001287 Guettarda speciosa Nutrition 0.000 claims description 4
- 239000002904 solvent Substances 0.000 claims description 4
- 241000903946 Clematidis Species 0.000 claims description 3
- 244000007853 Sarothamnus scoparius Species 0.000 claims description 3
- 239000002775 capsule Substances 0.000 claims description 3
- 238000001035 drying Methods 0.000 claims description 3
- 239000007938 effervescent tablet Substances 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- 239000002245 particle Substances 0.000 claims description 3
- 238000002791 soaking Methods 0.000 claims description 3
- 240000002505 Pogostemon cablin Species 0.000 claims description 2
- 235000011751 Pogostemon cablin Nutrition 0.000 claims description 2
- 238000001704 evaporation Methods 0.000 claims description 2
- 229940087559 grape seed Drugs 0.000 claims description 2
- 238000004806 packaging method and process Methods 0.000 claims description 2
- 238000007873 sieving Methods 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 19
- 238000011282 treatment Methods 0.000 abstract description 8
- 210000003205 muscle Anatomy 0.000 abstract description 7
- 238000000855 fermentation Methods 0.000 abstract description 5
- 230000004151 fermentation Effects 0.000 abstract description 5
- 206010059866 Drug resistance Diseases 0.000 abstract description 4
- 230000009286 beneficial effect Effects 0.000 abstract description 3
- 230000004936 stimulating effect Effects 0.000 abstract description 3
- 239000002994 raw material Substances 0.000 abstract description 2
- 241001397173 Kali <angiosperm> Species 0.000 abstract 1
- 210000001215 vagina Anatomy 0.000 description 11
- 239000002671 adjuvant Substances 0.000 description 10
- 208000003251 Pruritus Diseases 0.000 description 6
- 210000004185 liver Anatomy 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 210000000952 spleen Anatomy 0.000 description 5
- 241001529821 Agastache Species 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 230000001568 sexual effect Effects 0.000 description 4
- 241000382455 Angelica sinensis Species 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 102000009151 Luteinizing Hormone Human genes 0.000 description 3
- 108010073521 Luteinizing Hormone Proteins 0.000 description 3
- 241000972673 Phellodendron amurense Species 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 210000004877 mucosa Anatomy 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- 210000004291 uterus Anatomy 0.000 description 3
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 206010006784 Burning sensation Diseases 0.000 description 2
- 241000218158 Clematis Species 0.000 description 2
- 208000037093 Menstruation Disturbances Diseases 0.000 description 2
- 206010027339 Menstruation irregular Diseases 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 206010036618 Premenstrual syndrome Diseases 0.000 description 2
- 208000008350 Pruritus Vulvae Diseases 0.000 description 2
- 206010056530 Vulvovaginal pruritus Diseases 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000003467 diminishing effect Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000000686 essence Substances 0.000 description 2
- 229940011871 estrogen Drugs 0.000 description 2
- 239000000262 estrogen Substances 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 230000007803 itching Effects 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 229940040129 luteinizing hormone Drugs 0.000 description 2
- 238000010926 purge Methods 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 229940126680 traditional chinese medicines Drugs 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 241000205585 Aquilegia canadensis Species 0.000 description 1
- 208000004926 Bacterial Vaginosis Diseases 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 206010006298 Breast pain Diseases 0.000 description 1
- 241000005787 Cistanche Species 0.000 description 1
- 241000218202 Coptis Species 0.000 description 1
- 235000002991 Coptis groenlandica Nutrition 0.000 description 1
- 206010011409 Cross infection Diseases 0.000 description 1
- 241000234276 Curculigo Species 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 102000012673 Follicle Stimulating Hormone Human genes 0.000 description 1
- 108010079345 Follicle Stimulating Hormone Proteins 0.000 description 1
- 235000011201 Ginkgo Nutrition 0.000 description 1
- 235000008100 Ginkgo biloba Nutrition 0.000 description 1
- 244000194101 Ginkgo biloba Species 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010061217 Infestation Diseases 0.000 description 1
- 208000006877 Insect Bites and Stings Diseases 0.000 description 1
- 208000006662 Mastodynia Diseases 0.000 description 1
- 240000002853 Nelumbo nucifera Species 0.000 description 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 1
- 206010029803 Nosocomial infection Diseases 0.000 description 1
- 240000004371 Panax ginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 208000002500 Primary Ovarian Insufficiency Diseases 0.000 description 1
- 244000294611 Punica granatum Species 0.000 description 1
- 235000014360 Punica granatum Nutrition 0.000 description 1
- 241001404789 Smilax glabra Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 241000224526 Trichomonas Species 0.000 description 1
- 206010051873 Vaginal relaxation Diseases 0.000 description 1
- 208000037009 Vaginitis bacterial Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 206010000210 abortion Diseases 0.000 description 1
- 231100000176 abortion Toxicity 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000002605 anti-dotal effect Effects 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 239000012752 auxiliary agent Substances 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229960002152 chlorhexidine acetate Drugs 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 210000003016 hypothalamus Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 210000003041 ligament Anatomy 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 238000011866 long-term treatment Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 208000007106 menorrhagia Diseases 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000016087 ovulation Effects 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 210000003903 pelvic floor Anatomy 0.000 description 1
- 206010036601 premature menopause Diseases 0.000 description 1
- 208000017942 premature ovarian failure 1 Diseases 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- MCSINKKTEDDPNK-UHFFFAOYSA-N propyl propionate Chemical compound CCCOC(=O)CC MCSINKKTEDDPNK-UHFFFAOYSA-N 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 208000006379 syphilis Diseases 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 210000003905 vulva Anatomy 0.000 description 1
- 208000010484 vulvovaginitis Diseases 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/234—Cnidium (snowparsley)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/489—Sophora, e.g. necklacepod or mamani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/49—Fagaceae (Beech family), e.g. oak or chestnut
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/532—Agastache, e.g. giant hyssop
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/534—Mentha (mint)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/535—Perilla (beefsteak plant)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/716—Clematis (leather flower)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/718—Coptis (goldthread)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/82—Theaceae (Tea family), e.g. camellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/85—Verbenaceae (Verbena family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8967—Lilium, e.g. tiger lily or Easter lily
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/90—Smilacaceae (Catbrier family), e.g. greenbrier or sarsaparilla
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a compact antibacterial anti-vaginitis medicament containing capsule formula for female personal care, which comprises the following raw materials in parts by weight: 35-45% of grape seeds, 25-28% of glycerol, 15-20% of combined traditional Chinese medicine, 15-17% of vitex agnus-castus, 7-9% of vitamin E, 1.1-1.3% of cranberry and 0.9-1.1% of probiotics; the first formula of the combined traditional Chinese medicine comprises the following components in percentage by weight: 20-25% of wrinkled gianthyssop herb, 20-25% of perilla leaf, 15-17% of common cnidium fruit, 15-16.5% of argy wormwood leaf, 10-12% of Szechuan lovage rhizome and 10-12% of lily, wherein tendril-leaved kali has the characteristic of stimulating muscle convergence, is beneficial to adjusting the muscle strength of vaginal wall and recovering and exercising muscle, the probiotics adopts bacillus fermentation products, the drug resistance of human bodies to drugs after long-time use is reduced, the long-time use effect of the products is ensured, meanwhile, different formulas and proportions are adopted in the combined traditional Chinese medicine, and the whole product has good overall treatment effect on mycotic vaginitis and trichomonas vaginitis.
Description
Technical Field
The invention relates to the technical field of female personal care, in particular to a compact antibacterial anti-vaginitis medicine containing capsule formula for female personal care.
Background
The vaginitis is a common gynecological disease of the existing women, the overall morbidity is about 75 percent, wherein the morbidity of trichomonas vaginitis of the women is 10 to 25 percent, the morbidity of trichomonas vaginitis of the women in the sexual activity period is high, cross infection can be generated between the trichomonas vaginitis and the men, the men have no obvious disease display and are easy to become a group infection source; modern female life is relatively open, the age of the initial sexual life is small, according to data of ' Chinese female physiological health white paper ', the initial occurrence age of the group after 95 years is 17.71 years old, and according to the result of ' Chinese citizen ' sexual welfare nourishing survey ', 34 years old is the new life high-frequency occurrence cycle of Chinese people, and the need of private care is the most urgent time.
CN110859877A, the invention provides a tightening antibacterial composition for vagina, a tightening antibacterial medicine for vagina, a preparation method and an application, relating to the technical field of gynecological medicines, the tightening antibacterial composition for vagina provided by the invention comprises 0.1-2 parts of gallnut, 0.1-2 parts of honeysuckle, 0.1-2 parts of radix sophorae flavescentis, 0.1-2 parts of fructus cnidii, 0.1-2 parts of dark plum, 0.1-2 parts of coptis chinensis, 0.1-2 parts of angelica sinensis, 0.1-2 parts of bacillus fermentation product and the balance of auxiliary agent according to 100 parts of the sum of the contents of all the components. The components are used in a compatible manner in a specific ratio, so that bacterial vaginosis can be effectively treated, certain effects of inhibiting bacteria, resisting inflammation, improving organism immunity and repairing and tightening vagina are achieved, and the components are natural products, have no irritation to vaginal mucosa, avoid the harm of chemical drugs to organisms and effectively improve the physiological health and the life quality of patients;
CN107952018A, the application provides a female vagina contracting, cleaning and inflammation diminishing traditional Chinese medicine composition, which comprises the following raw material medicines in parts by weight: 25-70 parts of a curculigo rhizome extract, 20-45 parts of angelica sinensis, 15-45 parts of fructus cnidii, 20-50 parts of pomegranate rind, 5-40 parts of snow lotus herb, 3-15 parts of radix sophorae flavescentis, 5-15 parts of golden cypress, 5-40 parts of fructus kochiae, 5-10 parts of radix stemonae, 5-55 parts of herba epimedii, 5-38 parts of cistanche, 5-10 parts of chlorhexidine acetate, 2-20 parts of ginseng stem leaf saponin, 10-25 parts of ootheca mantidis and 10-22 parts of ginkgo. Has effects of repairing vaginal mucosa and cervical injury, can be easily absorbed by skin and mucosa in female private parts, and has effects of repairing elasticity, nourishing and regenerating muscles and ligaments of pelvic floor around vagina. Restoring vaginal tightness and elasticity, and improving vaginal relaxation, vaginal blowby and vaginal leakage caused by various reasons such as production, artificial abortion, frequent sexual life, aging, premature ovarian failure, etc. Is a traditional Chinese medicine composition which mainly contracts and tightens the female vagina and has the effects of warming uterus, expelling toxin, sterilizing, diminishing inflammation, nourishing the vagina, beautifying the vagina, protecting the vagina and the like
The prior art does not have the product, most of the research trends do not favor the research of female private care due to the influence of cultural background in China, and meanwhile due to the influence of culture, the research and the use of the product are not easily accepted by most people, trichomonas vaginitis belongs to the categories of 'pruritus vulvae' and 'leucorrhea' in traditional Chinese medicine, mainly refers to invasion of damp-heat, dysfunction of liver, kidney and spleen, liver vessels around the vulva apparatus, and also stores blood, and is the organ of the aeolian wood; kidneys store essence to govern reproduction and open into two yin meridians; the spleen governs transportation and transformation of water dampness, damp-heat in liver channel or liver depression and spleen deficiency to generate fire and dampness, damp-heat evil, downward flow of yin channel, accumulation of yin apparatus or infection of insect sting, insect harassment of the pudendum, and pruritus vulvae, trichomonas vaginitis is trichomonas parasitized in human vagina in western medicine, vulvovaginitis is caused under the condition of vaginal pH change, the long-term curative effect of pure western medicine treatment is poor, drug resistance is easy to generate, and the aim of thorough treatment cannot be achieved.
Disclosure of Invention
The invention aims to solve the defects that the long-term treatment effect of pure western medicine treatment in the prior art is poor, drug resistance is easy to generate, more side effects exist, and thorough treatment cannot be achieved, and provides a compact antibacterial anti-vaginitis medicament-containing capsule formula for female private care.
In order to achieve the purpose, the invention adopts the following technical scheme:
a compact antibacterial anti-vaginitis medicament containing capsule formula for female private care is designed, and the core formula is as follows: grape seed, glycerin, Vitex agnus-castus, vitamin E, combined traditional Chinese medicine, cranberry and probiotics;
the first formula of the combined traditional Chinese medicine comprises the following components in percentage by weight: 20 to 25 percent of wrinkled gianthyssop herb, 20 to 25 percent of perilla leaf, 15 to 17 percent of common cnidium fruit, 15 to 16.5 percent of argy wormwood leaf, 10 to 12 percent of szechuan lovage rhizome and 10 to 12 percent of lily;
the second formula of the combined traditional Chinese medicine comprises the following components in percentage by weight: 20 to 25 percent of broom cypress fruit, 18 to 25 percent of wrinkled gianthyssop herb, 18 to 25 percent of glabrous greenbrier rhizome, 13 to 15 percent of wild camellia, 10 to 15 percent of common cnidium fruit, 10 to 15 percent of scouring rush, 3 to 5 percent of mint and 2 to 3 percent of coptis chinensis;
the third formula of the combined traditional Chinese medicine comprises the following components in percentage by weight: 20-25% of perilla leaf, 18-22% of radix clematidis, 18-22% of angelica tail, 13-15% of fructus cnidii, 10-15% of carpesium laevigatum, 10-15% of aloe, 5-10% of radix sophorae flavescentis and 3-5% of mint.
Preferably, the core formulation is calculated as a percentage by weight: 35-45% of grape seeds, 25-28% of glycerol, 15-20% of combined traditional Chinese medicine, 15-17% of vitex agnus-castus, 7-9% of vitamin E, 1.1-1.3% of cranberry and 0.9-1.1% of probiotics.
Preferably, the cranberry is prepared by grinding purely air-dried fruits into powder, dissolving the cranberry in glycerol, grinding the cranberry into powder with the particle size of 1mm, sieving the powder with a 200-mesh sieve after grinding, and the probiotics is a bacillus fermentation product.
Preferably, in the first formula of the combined traditional Chinese medicine, the wrinkled gianthyssop herb is cablin potchouli herb, the common cnidium fruit is dried, fried and ground into powder for use, and the perilla leaf is dried and pressed for use.
Preferably, the second formula of the combined traditional Chinese medicine aims at mycotic vaginitis, wherein patchouli is adopted as wrinkled gianthyssop herb, phellodendron amurense is adopted as phellodendron amurense, Fujian is adopted as smilax glabra, coptis chinensis is adopted as coptis chinensis, and mint is produced from Jiangsu.
Preferably, the third formula of the combined traditional Chinese medicine aims at trichomonas vaginitis, and the mint is produced by Jiangsu mint.
Preferably, the first formula and the third formula of the combined traditional Chinese medicine are both treated by a nano-medicine method, and the second formula of the combined traditional Chinese medicine is treated by one of a capsule-packaging nano-medicine method and a soaking method after the effervescent tablets are dissolved.
Preferably, the effective components of the first formula and the second formula of the combined traditional Chinese medicine are dissolved in the glycerol liquid of the capsule.
Preferably, the Vitex agnus-castus is dissolved by an ethanol solvent to obtain a Vitex agnus-castus extract, and the Vitex agnus-castus extract is dried and evaporated by the ethanol solvent to obtain Vitex agnus-castus extract powder.
The compact antibacterial anti-vaginitis medicament containing capsule formula for female personal care provided by the invention has the beneficial effects that:
1. the core formula of the invention adopts the tendril Carli, has the characteristic of stimulating the convergence of muscles, is beneficial to adjusting the muscle strength of the vaginal wall and recovering and exercising the muscles, and simultaneously, the tendril Carli contains natural preservatives, can eliminate pruritus and simultaneously weaken the smell.
2. The vitex agnus-castus is added in the core formula, so that the concentration of estrogen and female hormone can be balanced, the hypogonadal gland and the hypothalamus can be influenced, FSH (follicle stimulating hormone) and LH (luteinizing hormone) can be helped to normalize to generate estrogen, meanwhile, the vitex agnus-castus, which is an effective component of the vitex agnus-castus, can inhibit climacteric syndrome, can increase the secretion of luteinizing hormone, can inhibit the secretion of hormone generated by stimulating follicles, and can reduce uncomfortable symptoms caused by premenstrual syndrome, and can help the luteinizing hormone secretion in females to restore to normal, can help to normalize ovulation, and treat irregular menstruation, premenstrual syndrome and mastalgia.
3. The probiotics in the core formula of the invention adopts bacillus fermentation products, thereby reducing the drug resistance of the human body to the drugs after long-time use and ensuring the long-time use effect of the products.
4. The second formula of the combined traditional Chinese medicine adopts belvedere fruit, wrinkled gianthyssop herb, glabrous greenbrier rhizome, wild camellia, common cnidium fruit, scouring rush, mint and golden thread, can reduce symptoms such as pruritus and the like when being soaked by an effervescent tablet, and has good treatment effect on mycotic vaginitis after the effective components are released when the soaking and medicine receiving methods are adopted.
5. The third formula of the combined traditional Chinese medicine adopts perilla leaf, clematis root, angelica tail, common cnidium fruit, old carpesium, aloe, radix sophorae flavescentis and mint, so that the combined traditional Chinese medicine has a good treatment effect on trichomonas vaginitis, and simultaneously, the aloe and the mint are added, so that the comfort of the product in use can be improved, and the burning sensation brought by a medicine taking method in the operation process is reduced.
Detailed Description
The following will clearly and completely describe the technical solutions in the embodiments of the present invention, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all embodiments.
Example 1
A compact antibacterial anti-vaginitis medicament containing capsule formula for female private care comprises the following core formula: grape seeds, glycerin, vitex agnus-castus, vitamin E, combined traditional Chinese medicines, tendril and Calli and probiotics, wherein the core formula comprises the following calculation percentages: 35-45% of grape seeds, 25-28% of glycerol, 15-20% of combined traditional Chinese medicines, 15-17% of vitex agnus-castus, 7-9% of vitamin E, 1.1-1.3% of cranberry and 0.9-1.1% of probiotics, wherein the vitex agnus-castus is dissolved by adopting an ethanol solvent to obtain a vitex agnus-castus extract, drying and evaporating the Vitex agnus-castus extract ethanol solution to obtain Vitex agnus-castus extract powder, grinding the Vitex agnus-castus extract powder into powder by adopting pure air-dried fruits, the cranberry is prepared by dissolving in glycerol, the crushed particle size of the cranberry is 1mm, the powder is sieved by a 200-mesh sieve after being crushed, the probiotics is a bacillus fermentation product, and the mixture is combined in a first formula of the traditional Chinese medicine, herba Agastaches is herba Agastaches, fructus Cnidii sun-dried, parched and ground into powder, folium Perillae sun-dried and pressed for use, and the effective components of the first formula of the combined Chinese medicinal materials are dissolved in glycerol liquid of the capsule.
The first formula of the combined traditional Chinese medicine comprises the following components in percentage by weight: 20 to 25 percent of wrinkled gianthyssop herb, 20 to 25 percent of perilla leaf, 15 to 17 percent of common cnidium fruit, 15 to 16.5 percent of argy wormwood leaf, 10 to 12 percent of szechuan lovage rhizome and 10 to 12 percent of lily;
example 2
The compact antibacterial anti-vaginitis capsule formula for female private care comprises the following combined traditional Chinese medicine second formula in percentage by weight: 20-25% of broom cypress fruit, 18-25% of wrinkled gianthyssop herb, 18-25% of glabrous greenbrier rhizome, 13-15% of wild camellia, 10-15% of common cnidium fruit, 10-15% of scouring rush herb, 3-5% of mint and 2-3% of golden thread, wherein the second formula of the combined traditional Chinese medicine aims at mycotic vaginitis, the wrinkled gianthyssop herb is adopted as the wrinkled giant hyssop, the golden cypress is adopted as the phellodendron amurense, the glabrous greenbrier rhizome is adopted as the Fujian product, the golden thread is adopted as the coptis chinensis, the mint is adopted as the Jiangsu product, active ingredients of the second formula of the combined traditional Chinese medicine are;
cortex Phellodendri (bitter in taste, cold in nature, kidney and bladder channels, heat-clearing and dampness-drying, fire-purging and steaming-removing, detoxifying and sore-curing), and adjuvant drugs are used for preventing other pungent drugs from generating burning sensation;
fructus kochiae (pungent, bitter, cold in nature, kidney and bladder channels, heat-clearing, dampness-removing, wind-dispelling, itching-relieving), adjuvant drug for treating pruritus;
herba Agastaches (warm, spleen, stomach, lung channel, aromatic, turbid pathogen eliminating, stomach harmonizing, vomiting relieving, exterior syndrome relieving, summer heat relieving, and antibacterial) as main ingredient, and has effects of killing bacteria, avoiding excessive drug taste, avoiding odor generation after product use, and containing herba Agastaches alcohol as main active ingredient;
rhizoma Smilacis Glabrae (rhizoma Smilacis Glabrae, and has effects of clearing away toxic materials, eliminating dampness, and relieving joint movement), has adjuvant drug effect, and can be used for inhibiting STDs such as syphilis;
the wild camellia (slightly pungent, bitter, astringent, neutral, liver-returning, spleen channel, blood circulation promoting, bleeding stopping, diarrhea stopping, detoxifying and sore healing) has the advantages of relieving irregular menstruation, having obvious effect on regulating menstruation and avoiding menorrhagia by using one adjuvant;
fructus cnidii (warm in nature and bitter in taste) and primary drugs are used for mainly treating trichomonas vaginitis, and relieving itching by external application, and the traditional Chinese medicine is used for mainly treating cold uterus;
scouring rush (sweet, bitter, Ping, entering lung and liver meridians) has the same flavor of adjuvant drugs to regulate the mild drug property in the prescription;
the mint (pungent and cool) adjuvant has the advantages that the use touch feeling is adjusted, the mint adjuvant is cool as much as possible, the medication comfort level is improved, and meanwhile, when the mint sodium is used, the contained menthol can adjust the abdominal pain;
coptis (Coptis chinensis (Roxb.) Craib) with the effects of clearing heat, eliminating dampness, purging fire, and removing toxicity), the adjuvant drug is one of the drugs, and the antidotal effect of the prescription is improved.
Example 3
The compact antibacterial anti-vaginitis capsule formula for female private care comprises the following combined traditional Chinese medicine third formula and calculated percentage: 20-25% of perilla leaf, 18-22% of radix clematidis, 18-22% of angelica tail, 13-15% of fructus cnidii, 10-15% of carpesium erectum, 10-15% of aloe, 5-10% of radix sophorae flavescentis and 3-5% of mint, wherein the third formula of the combined traditional Chinese medicine aims at trichomonas vaginitis, the mint is produced by Jiangsu mint, and the third formula of the combined traditional Chinese medicine is treated by a nano-medicine method;
clematis root (pungent, salty, warm in nature, entering bladder meridian) and adjuvant drugs can have good treatment effect on swelling and pain of hemorrhoids and can also have the effect of clearing away heat and toxic materials on private parts according to the explanation of 'surgical essences', so that the medication comfort level is improved;
folium Perillae (with analgesic, tranquilizing, and toxic materials removing effects, and strong inhibitory effect on Escherichia coli and Staphylococcus aureus), and primary medicine with strong antibacterial effect
The Chinese angelica and the tail (promoting blood circulation and removing blood stasis) are used as adjuvant medicines, are used for treating amenorrhea and blood stasis, accumulate and stagnation swelling and pain, and have a further blood circulation promoting effect on private parts, so that the compactness is improved in an auxiliary way;
fructus Cnidii (warm in nature and bitter in taste) and primary drug are used for treating trichomonas vaginitis, and relieving itching by external application, and the drug is used for treating cold uterus
The auxiliary medicine of the aged carpesium (bitter, pungent and flat) has one taste, and is suitable for treating abdominal pain caused by parasitic infestation after being aged for many years;
the main medicine of kuh-seng (bitter in taste, cold in nature, heart, liver, stomach, large intestine and bladder channels) is mainly used for treating trichomonas vaginitis.
The above description is only for the preferred embodiment of the present invention, but the scope of the present invention is not limited thereto, and any person skilled in the art should be considered to be within the technical scope of the present invention, and the technical solutions and the inventive concepts thereof according to the present invention should be equivalent or changed within the scope of the present invention.
Claims (9)
1. The compact antibacterial anti-vaginitis medicament containing capsule formula for female private care is characterized in that: the core formula is as follows: grape seed, glycerin, Vitex agnus-castus, vitamin E, combined traditional Chinese medicine, cranberry and probiotics;
the first formula of the combined traditional Chinese medicine comprises the following components in percentage by weight: 20 to 25 percent of wrinkled gianthyssop herb, 20 to 25 percent of perilla leaf, 15 to 17 percent of common cnidium fruit, 15 to 16.5 percent of argy wormwood leaf, 10 to 12 percent of szechuan lovage rhizome and 10 to 12 percent of lily;
the second formula of the combined traditional Chinese medicine comprises the following components in percentage by weight: 20 to 25 percent of broom cypress fruit, 18 to 25 percent of wrinkled gianthyssop herb, 18 to 25 percent of glabrous greenbrier rhizome, 13 to 15 percent of wild camellia, 10 to 15 percent of common cnidium fruit, 10 to 15 percent of scouring rush, 3 to 5 percent of mint and 2 to 3 percent of coptis chinensis;
the third formula of the combined traditional Chinese medicine comprises the following components in percentage by weight: 20-25% of perilla leaf, 18-22% of radix clematidis, 18-22% of angelica tail, 13-15% of fructus cnidii, 10-15% of carpesium laevigatum, 10-15% of aloe, 5-10% of radix sophorae flavescentis and 3-5% of mint.
2. The compact antibacterial anti-vaginitis nano-drug capsule formulation for personal care of women according to claim 1, wherein the compact antibacterial anti-vaginitis nano-drug capsule formulation comprises the following components in percentage by weight: the core formula is calculated as follows: 35-45% of grape seeds, 25-28% of glycerol, 15-20% of combined traditional Chinese medicine, 15-17% of vitex agnus-castus, 7-9% of vitamin E, 1.1-1.3% of cranberry and 0.9-1.1% of probiotics.
3. The compact antibacterial anti-vaginitis nano-drug capsule formulation for personal care of women according to claim 1, wherein the compact antibacterial anti-vaginitis nano-drug capsule formulation comprises the following components in percentage by weight: the cranberry is prepared by grinding pure air-dried fruits into powder, dissolving the cranberry in glycerol, grinding the cranberry into powder with the particle size of 1mm, sieving the powder with a 200-mesh sieve after grinding, and fermenting the probiotics by using bacillus.
4. The compact antibacterial anti-vaginitis nano-drug capsule formulation for personal care of women according to claim 1, wherein the compact antibacterial anti-vaginitis nano-drug capsule formulation comprises the following components in percentage by weight: in the first formula of the combined traditional Chinese medicine, the wrinkled gianthyssop herb is cablin patchouli herb, the common cnidium fruit is dried, fried and ground into powder for use, and the perilla leaf is dried and pressed for use.
5. The compact antibacterial anti-vaginitis nano-drug capsule formulation for personal care of women according to claim 1, wherein the compact antibacterial anti-vaginitis nano-drug capsule formulation comprises the following components in percentage by weight: the second formula of the combined traditional Chinese medicine aims at mycotic vaginitis, wherein patchouli is adopted as wrinkled gianthyssop herb, golden cypress is adopted as golden cypress, Fujian is adopted as glabrous greenbrier rhizome, golden thread is adopted as golden thread, and mint is produced from Jiangsu.
6. The compact antibacterial anti-vaginitis nano-drug capsule formulation for personal care of women according to claim 1, wherein the compact antibacterial anti-vaginitis nano-drug capsule formulation comprises the following components in percentage by weight: the third formula of the combined traditional Chinese medicine aims at trichomonas vaginitis, and the mint is produced by Jiangsu mint.
7. The compact antibacterial anti-vaginitis nano-drug capsule formulation for personal care of women according to claim 1, wherein the compact antibacterial anti-vaginitis nano-drug capsule formulation comprises the following components in percentage by weight: the first formula and the third formula of the combined traditional Chinese medicine are both treated by adopting a nano-medicine method, and the second formula of the combined traditional Chinese medicine adopts one of a capsule-packaging nano-medicine method and a soaking method after the effervescent tablets are dissolved.
8. The compact antibacterial anti-vaginitis nano-drug capsule formulation for personal care of women according to claim 1, wherein the compact antibacterial anti-vaginitis nano-drug capsule formulation comprises the following components in percentage by weight: the effective components of the first formula and the second formula are dissolved in the glycerin liquid of the capsule.
9. The compact antibacterial anti-vaginitis nano-drug capsule formulation for personal care of women according to claim 1, wherein the compact antibacterial anti-vaginitis nano-drug capsule formulation comprises the following components in percentage by weight: dissolving the Vitex agnus-castus by adopting an ethanol solvent to obtain a Vitex agnus-castus extract, and drying and evaporating the Vitex agnus-castus extract ethanol solution to obtain Vitex agnus-castus extract powder.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010665764.8A CN111671865A (en) | 2020-07-11 | 2020-07-11 | Compact antibacterial anti-vaginitis medicine containing capsule formula for female private nursing |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010665764.8A CN111671865A (en) | 2020-07-11 | 2020-07-11 | Compact antibacterial anti-vaginitis medicine containing capsule formula for female private nursing |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN111671865A true CN111671865A (en) | 2020-09-18 |
Family
ID=72438004
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010665764.8A Pending CN111671865A (en) | 2020-07-11 | 2020-07-11 | Compact antibacterial anti-vaginitis medicine containing capsule formula for female private nursing |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111671865A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113274487A (en) * | 2021-04-30 | 2021-08-20 | 杭州易启麦生物科技有限责任公司 | A natural herbal topical preparation with effects of resisting HPV virus, treating gynecological inflammation and promoting health, and its preparation method |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1048323A (en) * | 1989-06-28 | 1991-01-09 | 北京朝阳三益日用化学厂 | Prevent and treat the preparation method of acquired immune deficiency syndrome (AIDS), sexually transmitted disease (STD) washing liquid |
| CN108186770A (en) * | 2018-01-08 | 2018-06-22 | 吴海伦 | A kind of formula and preparation method of koro antibacterial liquid |
-
2020
- 2020-07-11 CN CN202010665764.8A patent/CN111671865A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1048323A (en) * | 1989-06-28 | 1991-01-09 | 北京朝阳三益日用化学厂 | Prevent and treat the preparation method of acquired immune deficiency syndrome (AIDS), sexually transmitted disease (STD) washing liquid |
| CN108186770A (en) * | 2018-01-08 | 2018-06-22 | 吴海伦 | A kind of formula and preparation method of koro antibacterial liquid |
Non-Patent Citations (1)
| Title |
|---|
| 朱丽君: "阴痒熏洗液治疗阴道炎150例", 《辽宁中医杂志》 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113274487A (en) * | 2021-04-30 | 2021-08-20 | 杭州易启麦生物科技有限责任公司 | A natural herbal topical preparation with effects of resisting HPV virus, treating gynecological inflammation and promoting health, and its preparation method |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20130108599A1 (en) | Herbal Vaginal Compositions | |
| CN104940727A (en) | Paste for treating rhinitis and preparation method thereof | |
| CN107308097A (en) | A kind of cosmetic constituent | |
| CN102008610B (en) | Traditional Chinese medicine composition for curing hyperosteogeny | |
| CN110841013A (en) | Lily footbath tablet for clearing heart and soothing nerves | |
| CN111671865A (en) | Compact antibacterial anti-vaginitis medicine containing capsule formula for female private nursing | |
| CN101856475B (en) | Chinese medicinal composition for treating gynecological inflammation and preparation method thereof | |
| CN106344460A (en) | Special moisturizing and acne-removing face cream for acne-prone skin and preparation method thereof | |
| CN103655735B (en) | One treats beriberi, the agent of skin pruritus foam washing | |
| CN103520348B (en) | The external traditional Chinese medicine oil for the treatment of hemorrhoid | |
| CN105381335B (en) | A kind of drug for treating eczema | |
| CN103721138A (en) | External traditional Chinese medicinal preparation for treating acne rosacea and preparation method thereof | |
| CN111991527A (en) | Foot medicated bath formula and preparation process thereof | |
| CN105616536A (en) | Traditional Chinese medicine liniment for treating leukoderma | |
| CN111184832A (en) | Plant probiotic composition with functions of contracting vagina, lubricating, nourishing and protecting nests and preparation method thereof | |
| CN104547794A (en) | Traditional Chinese medicine composition for treating bone fracture | |
| CN103977279A (en) | Traditional Chinese medicine additive for treating sow hysteritis and preparation method thereof | |
| CN110585379A (en) | External application medicine for treating dermatitis | |
| CN107095961A (en) | A kind of instant particles as Chinese medicine and preparation method for being used to treat adolescent acne | |
| CN113559195B (en) | Externally-applied hemorrhoid medicine, hemorrhoid steam lotion and preparation method thereof | |
| CN111700968A (en) | Compact, antibacterial and anti-inflammation medicine-containing capsule formula for female private care | |
| CN106362084B (en) | Dong's medicine for preventing gynecological diseases | |
| CN105535853A (en) | Traditional Chinese medicine composition for treating bedsores for clinical nursing | |
| CN105362944A (en) | Traditional Chinese medicine ointment for treating orthopedics sprain and contusion | |
| CN107198763A (en) | A kind of external application Chinese medicine for preventing and treating shank vein varicose and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200918 |
|
| RJ01 | Rejection of invention patent application after publication |